Skip to content
Baret News – Lifestyle
Author:
Tevogen Bio Inc
Tevogen Announces Formation of a Healthcare Services Initiative
June 9, 2026
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 22, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
May 21, 2026
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 20, 2026
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
1
2
Next Page
→